Flow Pharma and OncoImmunity AS partner for the Development of FlowVax Personalized Cancer Vaccines Read more
Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm Read more
FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin 1 Read more
Conference Chair from MedinCell invites you to attend Injectable Drug Delivery Conference 2019 Read more
Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies Read more